Autor: |
Taborda‐Barata, Luis, Ventura, Maria Teresa, Blain, Hubert, Brussino, Luisa, Kvedariene, Violeta, Larenas‐Linneman, Désirée E., Pham‐Thi, Nhân, Samolinski, Boleslaw, Fonseca, Joao A., Bousquet, Jean, Sousa‐Pinto, Bernardo |
Předmět: |
|
Zdroj: |
Clinical & Translational Allergy; Jan2023, Vol. 13 Issue 1, p1-5, 5p |
Abstrakt: |
Meaningful differences were observed for VAS eye (effect size = 0.47), VAS asthma (effect size = 0.84) and the combined symptom-medication score (effect size = 0.42), with higher median values being observed in older patients. In this study, we compared users <65 and >=65 years, namely regarding their demographic characteristics, reported allergy symptoms and reported medication use. For daily reported symptoms, differences in VAS global allergy symptoms and VAS nose were not meaningful. [Extracted from the article] |
Databáze: |
Complementary Index |
Externí odkaz: |
|
Nepřihlášeným uživatelům se plný text nezobrazuje |
K zobrazení výsledku je třeba se přihlásit.
|